Oncology Pharmacy Service Delivery during the COVID-19 pandemic 

An ISOPP led global oncology pharmacy group collaboration 

Extending on our ISOPP commentary which includes perspectives from practice leaders from 28 countries globally, we look forward to inviting your participation in a forthcoming individual member survey. 

This survey will aim to collate data on the way in which oncology pharmacy services were impacted by the COVID-19 pandemic and how pharmacy departments respond to the pandemic to deliver care to oncology patients. Information obtained from this survey will enable reflection on strategies and decisions (successful and unsuccessful) that could help move forward the pharmacy profession in the aftermath of the pandemic.

The ISOPP Research Committee has been working with a review panel of practice leaders and general practitioners and are now in the final stages of survey development. Distribution of the survey to memberships of participating oncology pharmacy associations is scheduled for September 1, 2020.  The ISOPP Research Committee would like to thank all participating review panel members for their time and efforts so far, this has truly been a global collaboration!  

Also, check out a recent ISOPP webinar on Global Oncology Pharmacy Response to COVID-19 Pandemic in ISOPP's Virtual Education Resource Library.